Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized (original) (raw)

• Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6–21 (2002).
  CAS PubMed Google Scholar
• Robertson, K. D. DNA methylation and human disease. Nature Rev. Genet. 6, 597–610 (2005). An excellent review of DNA methylation and human disease that documents the links between DNA methylation and cancer, DNA methylation and imprinting disorders, and DNA methylation and repeat-instability diseases.
  CAS PubMed Google Scholar
• Amir, R. E. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genet. 23, 185–188 (1999). This is the first report that mutations in MECP2 are responsible for Rett syndrome. Mutations were found in 25% of patients and the authors suggest a loss-of-function mechanism.
  CAS PubMed Google Scholar
• Fan, G. & Hutnick, L. Methyl-CpG binding proteins in the nervous system. Cell Res. 15, 255–261 (2005).
  CAS PubMed Google Scholar
• Klose, R. J. et al. DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol. Cell 19, 667–678 (2005).
  CAS PubMed Google Scholar
• Nan, X., Campoy, F. J. & Bird, A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88, 471–481 (1997).
  CAS PubMed Google Scholar
• Nan, X. et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386–389 (1998).
  CAS PubMed Google Scholar
• Jones, P. L. et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nature Genet. 19, 187–191 (1998). References 7 and 8 demonstrated ( in vitro and in cell-culture experiments) that, after binding to methylated CpG dinucleotides, MeCP2 can recruit histone deacetylase to a transcriptional-repressor complex and silence target genes. These studies prove for the first time that MBD-containing proteins such as MeCP2 can function as a molecular link between DNA methylation at promoter regions and transcriptional silencing.
  CAS PubMed Google Scholar
• Kokura, K. et al. The Ski protein family is required for MeCP2-mediated transcriptional repression. J. Biol. Chem. 276, 34115–34121 (2001).
  CAS PubMed Google Scholar
• Nan, X., Tate, P., Li, E. & Bird, A. DNA methylation specifies chromosomal localization of MeCP2. Mol. Cell. Biol. 16, 414–421 (1996).
  CAS PubMed PubMed Central Google Scholar
• Chandler, S. P., Guschin, D., Landsberger, N. & Wolffe, A. P. The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA. Biochemistry 38, 7008–7018 (1999).
  CAS PubMed Google Scholar
• Buschdorf, J. P. & Stratling, W. H. A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome. J. Mol. Med. 82, 135–143 (2004).
  CAS PubMed Google Scholar
• Kriaucionis, S. & Bird, A. The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res. 32, 1818–1823 (2004).
  CAS PubMed PubMed Central Google Scholar
• Mnatzakanian, G. N. et al. A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nature Genet. 36, 339–341 (2004). References 13 and 14 demonstrate that MeCP2 is subject to alternative splicing — generating two different N termini, one of which is significantly more abundant than the other — especially in the brain.
  CAS PubMed Google Scholar
• Amir, R. E. & Zoghbi, H. Y. Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations. Am. J. Med. Genet. 97, 147–152 (2000).
  CAS PubMed Google Scholar
• Miltenberger-Miltenyi, G. & Laccone, F. Mutations and polymorphisms in the human methyl CpG-binding protein MECP2. Hum. Mutat. 22, 107–115 (2003).
  CAS PubMed Google Scholar
• Weaving, L. S., Ellaway, C. J., Gecz, J. & Christodoulou, J. Rett syndrome: clinical review and genetic update. J. Med. Genet. 42, 1–7 (2005).
  CAS PubMed PubMed Central Google Scholar
• Philippe, C. et al. Spectrum and distribution of MECP2 mutations in 424 Rett syndrome patients: a molecular update. Eur. J. Med. Genet. 49, 9–18 (2006).
  CAS PubMed Google Scholar
• Schollen, E., Smeets, E., Deflem, E., Fryns, J. P. & Matthijs, G. Gross rearrangements in the MECP2 gene in three patients with Rett syndrome: implications for routine diagnosis of Rett syndrome. Hum. Mutat. 22, 116–120 (2003).
  CAS PubMed Google Scholar
• Laccone, F. et al. Large deletions of the MECP2 gene detected by gene dosage analysis in patients with Rett syndrome. Hum. Mutat. 23, 234–244 (2004).
  CAS PubMed Google Scholar
• Ravn, K. et al. Large genomic rearrangements in MECP2. Hum. Mutat. 25, 324 (2005).
  PubMed Google Scholar
• Shi, J. et al. Detection of heterozygous deletions and duplications in the MECP2 gene in Rett syndrome by Robust Dosage PCR (RD-PCR). Hum. Mutat. 25, 505 (2005).
  PubMed Google Scholar
• Archer, H. L. et al. Gross rearrangements of the MECP2 gene are found in both classical and atypical Rett Syndrome. J. Med. Genet. 23 Sep 2005 (doi:10.1136/jmg.2005.033464).
• Zappella, M., Meloni, I., Longo, I., Hayek, G. & Renieri, A. Preserved speech variants of the Rett syndrome: molecular and clinical analysis. Am. J. Med. Genet. 104, 14–22 (2001).
  CAS PubMed Google Scholar
• Charman, T. et al. Dimensional phenotypic analysis and functional categorisation of mutations reveal novel genotype-phenotype associations in Rett syndrome. Eur. J. Hum. Genet. 13, 1121–1130 (2005).
  CAS PubMed Google Scholar
• Jian, L. et al. p.R270X MECP2 mutation and mortality in Rett syndrome. Eur. J. Hum. Genet. 13, 1235–1238 (2005).
  CAS PubMed Google Scholar
• Ravn, K., Nielsen, J. B., Uldall, P., Hansen, F. J. & Schwartz, M. No correlation between phenotype and genotype in boys with a truncating MECP2 mutation. J. Med. Genet. 40, e5 (2003).
  CAS PubMed PubMed Central Google Scholar
• Kleefstra, T. et al. MECP2 analysis in mentally retarded patients: implications for routine DNA diagnostics. Eur. J. Hum. Genet. 12, 24–28 (2004).
  CAS PubMed Google Scholar
• Kudo, S. et al. Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain. J. Med. Genet. 40, 487–493 (2003).
  CAS PubMed PubMed Central Google Scholar
• Masuyama, T. et al. Classic Rett syndrome in a boy with R133C mutation of MECP2. Brain Dev. 27, 439–442 (2005).
  PubMed Google Scholar
• Orrico, A. et al. MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett. 481, 285–288 (2000).
  CAS PubMed Google Scholar
• Couvert, P. et al. MECP2 is highly mutated in X-linked mental retardation. Hum. Mol. Genet. 10, 941–946 (2001). This paper describes novel mutations in MECP2 that are not found in patients with Rett syndrome but in males with nonspecific mental retardation. Such mutations have been identified in families with recessively inherited mental retardation, and also in sporadic cases of mental retardation in males.
  CAS PubMed Google Scholar
• Cohen, D. et al. MECP2 mutation in a boy with language disorder and schizophrenia. Am. J. Psychiatry 159, 148–149 (2002).
  PubMed Google Scholar
• Thomas, G. H. High male:female ratio of germ-line mutations: an alternative explanation for postulated gestational lethality in males in X-linked dominant disorders. Am. J. Hum. Genet. 58, 1364–1368 (1996).
  CAS PubMed PubMed Central Google Scholar
• Girard, M. et al. Parental origin of de novo MECP2 mutations in Rett syndrome. Eur. J. Hum. Genet. 9, 231–236 (2001).
  CAS PubMed Google Scholar
• Trappe, R. et al. MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. Am. J. Hum. Genet. 68, 1093–1101 (2001).
  CAS PubMed PubMed Central Google Scholar
• Yntema, H. G. et al. Low frequency of MECP2 mutations in mentally retarded males. Eur. J. Hum. Genet. 10, 487–490 (2002).
  CAS PubMed Google Scholar
• Meins, M. et al. Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome. J. Med. Genet. 42, e12 (2005).
  CAS PubMed PubMed Central Google Scholar
• Van Esch, H. et al. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am. J. Hum. Genet. 77, 442–453 (2005). The authors demonstrate that, in addition to the defects that are caused by impaired or abolished MECP2 gene function, defects are also caused by increased MeCP2 dosage in humans, which results in a distinct phenotype. Duplications of the MECP2 region occur frequently in male patients with a severe form of mental retardation, which justifies quantitative screening of MECP2 in this group of patients.
  CAS PubMed PubMed Central Google Scholar
• Collins, A. L. et al. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum. Mol. Genet. 13, 2679–2689 (2004).
  CAS PubMed Google Scholar
• Weaving, L. S. et al. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am. J. Hum. Genet. 75, 1079–1093 (2004).
  CAS PubMed PubMed Central Google Scholar
• Tao, J. et al. Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. Am. J. Hum. Genet. 75, 1149–1154 (2004).
  CAS PubMed PubMed Central Google Scholar
• Mari, F. et al. Germline mosaicism in Rett syndrome identified by prenatal diagnosis. Clin. Genet. 67, 258–260 (2005).
  CAS PubMed Google Scholar
• Chen, R. Z., Akbarian, S., Tudor, M. & Jaenisch, R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nature Genet. 27, 327–331 (2001).
  CAS PubMed Google Scholar
• Guy, J., Hendrich, B., Holmes, M., Martin, J. E. & Bird, A. A mouse _Mecp2_-null mutation causes neurological symptoms that mimic Rett syndrome. Nature Genet. 27, 322–326 (2001).
  CAS PubMed Google Scholar
• Gemelli, T. et al. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice. Biol. Psychiatry 59, 468–476 (2005).
  PubMed Google Scholar
• Luikenhuis, S., Giacometti, E., Beard, C. F. & Jaenisch, R. Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc. Natl Acad. Sci. USA 101, 6033–6038 (2004).
  CAS PubMed PubMed Central Google Scholar
• Shahbazian, M. et al. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35, 243–254 (2002).
  CAS PubMed Google Scholar
• Young, J. I. & Zoghbi, H. Y. X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of Rett syndrome. Am. J. Hum. Genet. 74, 511–520 (2004).
  CAS PubMed PubMed Central Google Scholar
• Asaka, Y., Jugloff, D. G., Zhang, L., Eubanks, J. H. & Fitzsimonds, R. M. Hippocampal synaptic plasticity is impaired in the _Mecp2_-null mouse model of Rett syndrome. Neurobiol. Dis. 21, 217–227 (2006).
  CAS PubMed Google Scholar
• Moretti, P. et al. Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J. Neurosci. 26, 319–327 (2006).
  CAS PubMed PubMed Central Google Scholar
• Shahbazian, M. D., Antalffy, B., Armstrong, D. L. & Zoghbi, H. Y. Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum. Mol. Genet. 11, 115–124 (2002).
  CAS PubMed Google Scholar
• Akbarian, S. The neurobiology of Rett syndrome. Neuroscientist 9, 57–63 (2003).
  CAS PubMed Google Scholar
• Balmer, D., Goldstine, J., Rao, Y. M. & LaSalle, J. M. Elevated methyl-CpG-binding protein 2 expression is acquired during postnatal human brain development and is correlated with alternative polyadenylation. J. Mol. Med. 81, 61–68 (2003).
  CAS PubMed Google Scholar
• Samaco, R. C., Nagarajan, R. P., Braunschweig, D. & LaSalle, J. M. Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders. Hum. Mol. Genet. 13, 629–639 (2004).
  CAS PubMed Google Scholar
• LaSalle, J. M., Goldstine, J., Balmer, D. & Greco, C. M. Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry. Hum. Mol. Genet. 10, 1729–1740 (2001).
  CAS PubMed Google Scholar
• Armstrong, D., Dunn, J. K., Antalffy, B. & Trivedi, R. Selective dendritic alterations in the cortex of Rett syndrome. J. Neuropathol. Exp. Neurol. 54, 195–201 (1995).
  CAS PubMed Google Scholar
• Armstrong, D. D., Dunn, K. & Antalffy, B. Decreased dendritic branching in frontal, motor and limbic cortex in Rett syndrome compared with trisomy 21. J. Neuropathol. Exp. Neurol. 57, 1013–1017 (1998).
  CAS PubMed Google Scholar
• Kishi, N. & Macklis, J. D. MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol. Cell. Neurosci 27, 306–321 (2004).
  CAS PubMed Google Scholar
• Cusack, S. M. et al. Suppression of MeCP2β expression inhibits neurite extension in PC12 cells. Exp. Cell Res. 299, 442–453 (2004).
  CAS PubMed Google Scholar
• Kaufmann, W. E., Naidu, S. & Budden, S. Abnormal expression of microtubule-associated protein 2 (MAP-2) in neocortex in Rett syndrome. Neuropediatrics 26, 109–113 (1995).
  CAS PubMed Google Scholar
• Johnston, M. V., Jeon, O. H., Pevsner, J., Blue, M. E. & Naidu, S. Neurobiology of Rett syndrome: a genetic disorder of synapse development. Brain Dev. 23, S206–S213 (2001).
  PubMed Google Scholar
• Colantuoni, C. et al. Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification. Neurobiol. Dis. 8, 847–865 (2001).
  CAS PubMed Google Scholar
• Pescucci, C. et al. Chromosome 2 deletion encompassing the MAP2 gene in a patient with autism and Rett-like features. Clin. Genet. 64, 497–501 (2003).
  CAS PubMed Google Scholar
• Nan, X., Cross, S. & Bird, A. Gene silencing by methyl-CpG-binding proteins. Novartis Found. Symp. 214, 6–50 (1998).
  CAS PubMed Google Scholar
• Wan, M., Zhao, K., Lee, S. S. & Francke, U. MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome. Hum. Mol. Genet. 10, 1085–1092 (2001).
  CAS PubMed Google Scholar
• Kaufmann, W. E. et al. Histone modifications in Rett syndrome lymphocytes: a preliminary evaluation. Brain Dev. 27, 331–339 (2005).
  PubMed Google Scholar
• Kouzarides, T. Histone methylation in transcriptional control. Curr. Opin. Genet. Dev. 12, 198–209 (2002).
  CAS PubMed Google Scholar
• Fuks, F. et al. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem. 278, 4035–4040 (2003).
  CAS PubMed Google Scholar
• Fuks, F., Hurd, P. J., Deplus, R. & Kouzarides, T. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res. 31, 2305–2312 (2003).
  CAS PubMed PubMed Central Google Scholar
• Georgel, P. T. et al. Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J. Biol. Chem. 278, 32181–32188 (2003).
  CAS PubMed Google Scholar
• Traynor, J., Agarwal, P., Lazzeroni, L. & Francke, U. Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations. BMC Med. Genet. 3, 12 (2002).
  PubMed PubMed Central Google Scholar
• Tudor, M., Akbarian, S., Chen, R. Z. & Jaenisch, R. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc. Natl Acad. Sci. USA 99, 15536–15541 (2002).
  CAS PubMed PubMed Central Google Scholar
• Ballestar, E. et al. The impact of MECP2 mutations in the expression patterns of Rett syndrome patients. Hum. Genet. 116, 91–104 (2005).
  CAS PubMed Google Scholar
• Matarazzo, V. & Ronnett, G. V. Temporal and regional differences in the olfactory proteome as a consequence of MeCP2 deficiency. Proc. Natl Acad. Sci. USA 101, 7763–7768 (2004).
  CAS PubMed PubMed Central Google Scholar
• Nuber, U. A. et al. Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome. Hum. Mol. Genet. 14, 2247–2256 (2005).
  CAS PubMed Google Scholar
• Martinowich, K. et al. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302, 890–893 (2003).
  CAS PubMed Google Scholar
• Chen, W. G. et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302, 885–889 (2003). References 77 and 78 show that MeCP2 binds selectively to the BDNF promoter and represses the dynamic expression of BDNF , which is regulated by neuronal activity. These reports indicate that the deregulation of activity-dependent transcription that occurs when MECP2 is mutated could affect synaptic development and contribute to the pathology of Rett syndrome.
  CAS PubMed Google Scholar
• Webster, M. J., Weickert, C. S., Herman, M. M. & Kleinman, J. E. BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex. Brain Res. Dev. Brain Res. 139, 139–150 (2002).
  CAS PubMed Google Scholar
• Scharfman, H. E. Brain-derived neurotrophic factor and epilepsy — a missing link? Epilepsy Curr. 5, 83–88 (2005).
  PubMed PubMed Central Google Scholar
• Yamada, K. & Nabeshima, T. Brain-derived neurotrophic factor/TrkB signaling in memory processes. J. Pharmacol. Sci. 91, 267–270 (2003).
  CAS PubMed Google Scholar
• Croll, S. D. et al. Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex. Neuroscience 93, 1491–1506 (1999).
  CAS PubMed Google Scholar
• Richerson, G. B. & Bekkers, J. M. Learning to take a deep breath — with BDNF. Nature Med. 10, 25–26 (2004).
  CAS PubMed Google Scholar
• Gorski, J. A., Zeiler, S. R., Tamowski, S. & Jones, K. R. Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. J. Neurosci. 23, 6856–6865 (2003).
  CAS PubMed PubMed Central Google Scholar
• Gorski, J. A., Balogh, S. A., Wehner, J. M. & Jones, K. R. Learning deficits in forebrain-restricted brain-derived neurotrophic factor mutant mice. Neuroscience 121, 341–354 (2003).
  CAS PubMed Google Scholar
• Chang, Q., Khare, G., Dani, V., Nelson, S. & Jaenisch, R. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 49, 341–348 (2006). The authors provide the first in vivo evidence for a functional interaction between MeCP2 and BDNF in mice and demonstrate that brain BDNF levels can modulate Rett disease progression.
  CAS PubMed Google Scholar
• Makedonski, K., Abuhatzira, L., Kaufman, Y., Razin, A. & Shemer, R. MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression. Hum. Mol. Genet. 14, 1049–1058 (2005). The authors describe epigenetic aberrations at the Prader Willi syndrome–Angelman syndrome imprinting centre in patients with Rett and MeCP2-deficient mice. These changes result in loss of imprinting of the UBE3A antisense gene in the brain, an increase in UBE3A antisense RNA levels and, consequently, reduction in UBE3A protein production.
  CAS PubMed Google Scholar
• Horike, S., Cai, S., Miyano, M., Cheng, J. F. & Kohwi-Shigematsu, T. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nature Genet. 37, 31–40 (2005).
  CAS PubMed Google Scholar
• Samaco, R. C., Hogart, A. & LaSalle, J. M. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum. Mol. Genet. 14, 483–492 (2005).
  CAS PubMed Google Scholar
• Williams, C. A. Neurological aspects of the Angelman syndrome. Brain Dev. 27, 88–94 (2005).
  PubMed Google Scholar
• Young, J. I. et al. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc. Natl Acad. Sci. USA 102, 17551–1758 (2005). This is the first study to describe a function of MeCP2 in the regulation of splicing, in addition to its role as a transcriptional repressor.
  CAS PubMed PubMed Central Google Scholar
• Mu, Y., Otsuka, T., Horton, A. C., Scott, D. B. & Ehlers, M. D. Activity-dependent mRNA splicing controls ER export and synaptic delivery of NMDA receptors. Neuron 40, 581–594 (2003).
  CAS PubMed Google Scholar
• Stancheva, I., Collins, A. L., Van den Veyver, I. B., Zoghbi, H. & Meehan, R. R. A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos. Mol. Cell 12, 425–435 (2003).
  CAS PubMed Google Scholar
• Kornblihtt, A. R., de la Mata, M., Fededa, J. P., Munoz, M. J. & Nogues, G. Multiple links between transcription and splicing. RNA 10, 1489–1498 (2004).
  CAS PubMed PubMed Central Google Scholar